A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations
Endeavor Biomedicines, Inc.
Endeavor Biomedicines, Inc.
Eli Lilly and Company
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Massachusetts General Hospital
Milton S. Hershey Medical Center
Massachusetts General Hospital